{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:57:54Z","timestamp":1791464274312,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1245\/s10434-018-6700-6","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T14:42:55Z","timestamp":1534776175000},"page":"3701-3708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study"],"prefix":"10.1245","volume":"25","author":[{"given":"Claudia","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Musella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"D\u2019Indinosante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Capoluongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Benedetti Panici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"6700_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced- stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013; 10: 211\u2013224.","journal-title":"Nat Rev Clin Oncol"},{"key":"6700_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","volume":"9","author":"M Markman","year":"1991","unstructured":"Markman M, Rothman R, Hakes T, et al. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol. 1991;9:389\u2013393.","journal-title":"J Clin Oncol"},{"key":"6700_CR3","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/annonc\/mdq577","volume":"22","author":"DJ Gallagher","year":"2011","unstructured":"Gallagher DJ, Konner JA, Bell-McGuinn KM, et al. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol. 2011; 22:1127\u20131132.","journal-title":"Ann Oncol"},{"issue":"3","key":"6700_CR4","doi-asserted-by":"publisher","first-page":"334.e1","DOI":"10.1016\/j.ajog.2017.05.036","volume":"217","author":"M Petrillo","year":"2017","unstructured":"Petrillo M, Marchetti C, De Leo R, et al. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study. Am J Obstet Gynecol. 2017; 217(3): 334.e1\u2013334.e9.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"6700_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ygyno.2017.04.011","volume":"146","author":"MA Bookman","year":"2017","unstructured":"Bookman MA, Tyczynski JE, Espirito JL,Wilson TW, Fernandes AW. Impact of primary platinum-free interval and BRCA1\/2 mutation status on treatment and survival in patients with recurrent ovarian cancer. Gynecol Oncol. 2017;146(1): 58\u201363.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6700_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/annonc\/mdv608","volume":"27","author":"D Lorusso","year":"2016","unstructured":"Lorusso D, Scambia G, Pignata S, et al. Prospective phase II trial of trabectedin in BRCA-mutated and\/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial. Ann Oncol. 2016; 27(3):487\u201393.","journal-title":"Ann Oncol"},{"key":"6700_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40661-016-0024-7","volume":"3","author":"RS Meehan","year":"2016","unstructured":"Meehan RS, Chen AP. New treatment option for ovarian cancer: PARP inhibitors. Gynecol Oncol Res Pract. 2016;3:3.","journal-title":"Gynecol Oncol Res Pract."},{"issue":"3\u20134","key":"6700_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000159266","volume":"75","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Fanfani F, Rossitto C, et al. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy. Oncology. 2008;75(3\u20134):152\u20138.","journal-title":"Oncology"},{"issue":"2","key":"6700_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1245\/s10434-014-4011-0","volume":"22","author":"F Fanfani","year":"2015","unstructured":"Fanfani F, Monterossi G, Fagotti A, et al. Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol. 2015;22(2):649\u201354.","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"6700_CR10","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","volume":"42","author":"G Ferrandina","year":"2006","unstructured":"Ferrandina G, Legge F, Salutari V, Paglia A, Testa A, Scambia G. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations. Eur J Cancer. 2006;42(14):2296\u2013302.","journal-title":"Eur J Cancer"},{"issue":"4","key":"6700_CR11","doi-asserted-by":"publisher","first-page":"e000080","DOI":"10.1136\/esmoopen-2016-000080","volume":"1","author":"CC Zielinski","year":"2006","unstructured":"Zielinski CC, Pinto C. AIOM chooses ESMO Open\u2014Cancer Horizons as its official journal: a warm welcome from ESMO Open. ESMO Open. 2016;1(4):e000080.","journal-title":"ESMO Open"},{"issue":"10","key":"6700_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1586\/14737159.2015.1081059","volume":"15","author":"A Minucci","year":"2015","unstructured":"Minucci A, Scambia G, Santonocito C, et al. Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review. Expert Rev Mol Diagn. 2015;15(10):1383\u2013403.","journal-title":"Expert Rev Mol Diagn"},{"key":"6700_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3892\/mco.2014.251","volume":"2","author":"L Balabanski","year":"2014","unstructured":"Balabanski L, Antov G, Dimova I, et al. Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects. Mol Clin Oncol. 2014;2:435\u20139.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"6700_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-017-4275-8","volume":"164","author":"P Concolino","year":"2017","unstructured":"Concolino P, Rizza R, Hackmann K, et al. Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome. Breast Cancer Res Treat. 2017;164(2):497\u2013503.","journal-title":"Breast Cancer Res Treat"},{"key":"6700_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cca.2014.06.026","volume":"437","author":"P Concolino","year":"2014","unstructured":"Concolino P, Costella A, Minucci A, et al. A preliminary quality control (QC) for next-generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1\/2 deleterious mutations. Clin Chim Acta. 2014;437:72\u20137.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"6700_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.seminoncol.2017.08.004","volume":"44","author":"E Capoluongo","year":"2017","unstructured":"Capoluongo E, Ellison G, L\u00f3pez-Guerrero JA, et al. Guidance statement on BRCA1\/2 tumor testing in ovarian cancer patients. Semin Oncol. 2017;44(3):187\u2013197.","journal-title":"Semin Oncol"},{"key":"6700_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cca.2017.04.026","volume":"470","author":"A Minucci","year":"2017","unstructured":"Minucci A, De Paolis E, Concolino P, et al. Competitive PCR-High Resolution Melting Analysis (C-PCR-HRMA) for large genomic rearrangements (LGRs) detection: a new approach to assess quantitative status of BRCA1 gene in a reference laboratory. Clin Chim Acta. 2017;470:83\u201392.","journal-title":"Clin Chim Acta"},{"issue":"49","key":"6700_CR18","doi-asserted-by":"publisher","first-page":"81357","DOI":"10.18632\/oncotarget.12877","volume":"7","author":"C Badoer","year":"2016","unstructured":"Badoer C, Garrec C, Goossens D, et al. Performance of multiplicom\u2019s BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples. Oncotarget. 2016;7(49):81357\u201381366.","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"6700_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ejhg.2016.92","volume":"24","author":"E Capoluongo","year":"2016","unstructured":"Capoluongo E. BRCA to the future: towards best testing practice in the era of personalised healthcare. Eur J Hum Genet. 2016;24 Suppl 1:S1-2.","journal-title":"Eur J Hum Genet."},{"key":"6700_CR20","unstructured":"BRCA Germline I Reference Standard gDNA. Available at: \n                    https:\/\/www.horizondiscovery.com\/brca-germline-i-hd793\n                    \n                  ."},{"issue":"1","key":"6700_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2016.03.037","volume":"142","author":"M Petrillo","year":"2016","unstructured":"Petrillo M, Nero C, Amadio G, Gallo D, Fagotti A, Scambia G. Targeting the hallmarks of ovarian cancer: the big picture. Gynecol Oncol. 2016;142(1):176\u2013183.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6700_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ygyno.2009.11.023","volume":"116","author":"F Fanfani","year":"2010","unstructured":"Fanfani F, Fagotti A, Gallotta V, et al. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. Gynecol Oncol. 2010;116(3):497\u2013501.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6700_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","volume":"14","author":"P Benedetti Panici","year":"2007","unstructured":"Benedetti Panici P, De Vivo A, Bellati F, et al. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol. 2007; 14(3):1136\u201342.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6700_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1245\/s10434-006-9048-2","volume":"13","author":"N Manci","year":"2006","unstructured":"Manci N, Bellati F, Muzii L, et al. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data. Ann Surg Oncol. 2006; 13(12):1717\u201323.","journal-title":"Ann Surg Oncol"},{"key":"6700_CR25","first-page":"613980","volume":"2012","author":"D Lorusso","year":"2012","unstructured":"Lorusso D, Mancini M, Di Rocco R, Fontanelli R, Raspagliesi F. The role of secondary surgery in recurrent ovarian cancer. Int J Surg Oncol. 2012;2012:613980.","journal-title":"J Surg Oncol"},{"key":"6700_CR26","doi-asserted-by":"crossref","unstructured":"Du Bois A, Vergote I, Ferron G, et al. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20. J Clin Oncol. 2017; 35 Suppl: abstract no. 5501.","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"key":"6700_CR27","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, Du Bois A, Hahmann M, et al. Suregery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol. 2006;13:1702\u201310.","journal-title":"Ann Surg Oncol"},{"key":"6700_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","volume":"19","author":"WJ Tian","year":"2012","unstructured":"Tian WJ, Chi DS, Sehouli J, et al. A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Ann Surg Oncol. 2012;19:597\u2013604.","journal-title":"Ann Surg Oncol"},{"key":"6700_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1200\/JCO.2002.20.2.463","volume":"20","author":"Y Ben David","year":"2002","unstructured":"Ben David Y, Chetrit A, Hirsh-Yechezkel G, et al. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol. 2002;20:463\u2013466.","journal-title":"J Clin Oncol"},{"key":"6700_CR30","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","volume":"26","author":"DS Tan","year":"2008","unstructured":"Tan DS, Rothermundt C, Thomas K, et al. \u201cBRCAness\u201d syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol. 2008;26:5530\u20135536.","journal-title":"J Clin Oncol"},{"issue":"5","key":"6700_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40291-017-0288-6","volume":"21","author":"P Concolino","year":"2017","unstructured":"Concolino P, Rizza R, Hackmann K, et al. Identification and characterization of a new BRCA2 Rearrangement in an Italian family with hereditary breast and ovarian cancer syndrome. Mol Diagn Ther. 2017;21(5):539\u2013545.","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"6700_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/IGC.0000000000001065","volume":"27","author":"X Wu","year":"2017","unstructured":"Wu X, Wu L, Kong B, et al. The first nationwide multicenter prevalence study of germline BRCA1 and BRCA2 mutations in Chinese ovarian cancer patients. Int J Gynecol Cancer. 2017;27(8):1650\u20131657.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"6700_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4143\/crt.2017.220","volume":"50","author":"KJ Eoh","year":"2018","unstructured":"Eoh KJ, Kim JE, Park HS, et al. Detection of Germline mutations in patients with epithelial ovarian cancer using multi-gene panels: beyond BRCA1\/2. Cancer Res Treat. 2018;50(3):917\u2013925.","journal-title":"Cancer Res Treat."}],"updated-by":[{"DOI":"10.1245\/s10434-018-6726-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6700-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T15:03:35Z","timestamp":1600268615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["6700"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6700-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"24 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of the article, Angelo Minucci\u2019s last name was spelled incorrectly. It is correct as shown here. The original article has been corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of the article, Angelo Minucci?s last name was spelled incorrectly. It is correct as shown here. The original article has been corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of the article, Angelo Minucci?s last name was spelled incorrectly. It is correct as shown here. The original article has been corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Claudia Marchetti, Rossella De Leo, Angela Musella, Marco D\u2019Indinosante, Ettore Capoluongo, Angelo Minucci, Pierluigi Benedetti Panici, Giovanni Scambia, and Anna Fagotti declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}